BETHLEHEM, Pa. -- B. Braun Medical Inc. joins the International Sharps Injury Prevention Society (ISIPS) in commemorating the second annual International Sharps Injury Prevention Awareness Month.
According to ISIPS, 2 million healthcare workers worldwide are accidentally stuck by sharps each year. Because of sharps injuries, more than three dozen U.S. healthcare workers a year contract HIV, 2,000 workers a year become infected with hepatitis C, and 400 contract hepatitis B.
The goal of ISIPS is to raise awareness of the dangers to health professional and patients through needle stick injuries and solutions now available to reduce hospital-setting risks.
B. Braun develops sharps with passive safety features that remain in effect before, during, and after use. These automatic safety features do not need to be self-activated, and are more likely than active features to have a greater impact on prevention. In an evaluation of 79 hospitals, most needlestick injuries were cause by inactivated and improperly activated sharps safety devices.
"Our mission is to make healthcare delivery safer for the patient and healthcare practitioner alike," said Caroll Neubauer, chairman and CEO of B. Braun Medical. "Like air bags in cars, passive safety mechanisms on medical devices provide the support necessary to reduce needle-stick injuries for medical professionals without interfering in performance. Innovation and information are key risk prevention tools."
Source: B. Braun
Second Strain of Bird Flu Found in US Dairy Cows: What It Means for Infection Prevention and Control
February 7th 2025A new H5N1 strain was found in Nevada dairy cows, challenging earlier transmission theories. This raises concerns about animal vulnerability, human health risks, and food safety. Experts emphasize the need for improved surveillance, biosecurity, and cross-sector collaboration to contain the virus spread.
Fungal Infections: The Silent Epidemic Threatening Global Health
February 6th 2025Fungal infections are a rising global threat, with antifungal resistance complicating treatment. Neil J. Clancy, MD, emphasizes the urgent need for research, better diagnostics, and stronger infection prevention strategies.